From Nasdaq: 2025-05-01 08:50:00

Short-term investing can be profitable, but sustaining a trend is crucial. Factors like sound fundamentals and positive earnings estimates are key. The “Recent Price Strength” screen helps identify stocks trading near their highs, like ADMA Biologics, up 41.1% in 12 weeks and 17.7% in 4 weeks, with a Zacks Rank #2 (Buy).

ADMA Biologics is a strong candidate for short-term investment, with solid price performance and positive fundamentals. The stock is currently trading near its 52-week high and has a Zacks Rank #2 (Buy) and an Average Broker Recommendation of #1 (Strong Buy), indicating potential for further price gains. The stock may continue its upward trend.

In addition to ADMA, other stocks meeting the criteria of the “Recent Price Strength” screen may also be worth considering for short-term investment. The screen helps identify stocks with strong price momentum and positive fundamentals, making them potential winners for trend investors.

Zacks Research offers various tools to help investors find profitable stock picks, such as the Research Wizard. Backtesting strategies and using successful stock-picking methods can enhance investment decisions. Sign up for a free trial today to access these tools and improve your stock-picking strategy.



Read more at Nasdaq: Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here’s Why